BEGIN:VCALENDAR
PRODID:-//github.com/rianjs/ical.net//NONSGML ical.net 4.0//EN
VERSION:2.0
BEGIN:VEVENT
DESCRIPTION:In this session\, Dr. Vladimir Muzykantov will present an in-d
 epth analysis of the current advances and challenges in drug targeting\, 
 biomaterials\, nanomedicine\, drug delivery systems (DDS)\, intracellular
  delivery\, and biotherapeutics (Bios).\n\nHighlights of the presentation
 Biotherapeutics (Bios) as a new pharmacological class: Discussion of thei
 r catalytic precision\, biological potency\, and delivery challenges with
 in systemic circulation.Delivery challenges and bottlenecks: Exploration 
 of nanoscale targeting requirements\, intracellular addressing (cytosol v
 s nucleus)\, and barriers to effective biodistribution and clearance.Cogn
 izant vs. Fortuitous Targeting Approaches: Comparison of rational ligand-
 based targeting versus chance discoveries ("fortuitous homing")\, includi
 ng advantages\, limitations\, and potential synergies.Mechanistic underst
 anding through DDS design: How tracing\, modeling\, and controlled modifi
 cation of nanocarriers advance rational design for vascular delivery.Re-e
 ngineering Fortuitous Nanocarriers: Strategies to transform serendipitous
  findings into predictable and tunable delivery platforms through modulat
 ion of carrier configuration\, size\, shape\, and biological context.Tran
 slational impact — Vascular Nanomedicine: Case studies where endothelial-
 targeted antioxidants\, antithrombotics\, and anti-inflammatory agents ou
 tperform untargeted drugs in animal models of lung injury\, ischemia-repe
 rfusion\, and sepsis.\n
DTEND:20251212T110000
DTSTAMP:20260512T232948Z
DTSTART:20251212T100000
LOCATION:\,
SEQUENCE:0
SUMMARY:In this session\, Dr. Vladimir Muzykantov will present an in-depth
  analysis of the current advances and challenges in drug targeting\, biom
 aterials\,...
UID:922b32d9-a6e7-4a99-8405-5021dff82609
END:VEVENT
END:VCALENDAR